Global Anti-Parkinson Drugs Market Size, Status and Forecast 2021-2027

Anti-Parkinson Drugs are drugs used to treat Parkinson's disease.

The most commonly used Anti-Parkinson Drugs act on the dopaminergic system of the striatum and basal ganglia, or are central muscarinic antagonists.

Market Analysis and Insights: Global Anti-Parkinson Drugs Market

The global Anti-Parkinson Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti-Parkinson Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti-Parkinson Drugs market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti-Parkinson Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti-Parkinson Drugs market.

Global Anti-Parkinson Drugs Scope and Market Size

Anti-Parkinson Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Parkinson Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Dopaminergic

Dopamine Agonists

Enzyme Inhibitors

Others

Hospital Pharmacy

Retail Pharmacy

Online Stores

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Nordic

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

AbbVie

Mylan Laboratories

Valeant Pharmaceuticals

Novartis

GlaxoSmithKline

Zambon Pharmaceuticals

Pfizer, Inc.

Hoffmann-La Roche

Merck & Co.

Orion Pharma

UCB

Teva Pharmaceutical Industries Ltd.

Vertical Pharmaceuticals, LLC

ACADIA Pharmaceuticals Inc.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Anti-Parkinson Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027

1.2.2 Dopaminergic

1.2.3 Dopamine Agonists

1.2.4 Enzyme Inhibitors

1.2.5 Others

1.3 Market by Application

1.3.1 Global Anti-Parkinson Drugs Market Share by Application: 2016 VS 2021 VS 2027

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Online Stores

1.4 Study Objectives

1.5 Years Considered

2.1 Global Anti-Parkinson Drugs Market Perspective (2016-2027)

2.2 Anti-Parkinson Drugs Growth Trends by Regions

2.2.1 Anti-Parkinson Drugs Market Size by Regions: 2016 VS 2021 VS 2027

2.2.2 Anti-Parkinson Drugs Historic Market Share by Regions (2016-2021)

2.2.3 Anti-Parkinson Drugs Forecasted Market Size by Regions (2022-2027)

2.3 Anti-Parkinson Drugs Industry Dynamic

2.3.1 Anti-Parkinson Drugs Market Trends

2.3.2 Anti-Parkinson Drugs Market Drivers

2.3.3 Anti-Parkinson Drugs Market Challenges

2.3.4 Anti-Parkinson Drugs Market Restraints

3.1 Global Top Anti-Parkinson Drugs Players by Revenue

3.1.1 Global Top Anti-Parkinson Drugs Players by Revenue (2016-2021)

3.1.2 Global Anti-Parkinson Drugs Revenue Market Share by Players (2016-2021)

3.2 Global Anti-Parkinson Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.3 Players Covered: Ranking by Anti-Parkinson Drugs Revenue

3.4 Global Anti-Parkinson Drugs Market Concentration Ratio

3.4.1 Global Anti-Parkinson Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Anti-Parkinson Drugs Revenue in 2020

3.5 Anti-Parkinson Drugs Key Players Head office and Area Served

3.6 Key Players Anti-Parkinson Drugs Product Solution and Service

3.7 Date of Enter into Anti-Parkinson Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Anti-Parkinson Drugs Historic Market Size by Type (2016-2021)

4.2 Global Anti-Parkinson Drugs Forecasted Market Size by Type (2022-2027)

5.1 Global Anti-Parkinson Drugs Historic Market Size by Application (2016-2021)

5.2 Global Anti-Parkinson Drugs Forecasted Market Size by Application (2022-2027)

6.1 North America Anti-Parkinson Drugs Market Size (2016-2027)

6.2 North America Anti-Parkinson Drugs Market Size by Type

6.2.1 North America Anti-Parkinson Drugs Market Size by Type (2016-2021)

6.2.2 North America Anti-Parkinson Drugs Market Size by Type (2022-2027)

6.2.3 North America Anti-Parkinson Drugs Market Size by Type (2016-2027)

6.3 North America Anti-Parkinson Drugs Market Size by Application

6.3.1 North America Anti-Parkinson Drugs Market Size by Application (2016-2021)

6.3.2 North America Anti-Parkinson Drugs Market Size by Application (2022-2027)

6.3.3 North America Anti-Parkinson Drugs Market Size by Application (2016-2027)

6.4 North America Anti-Parkinson Drugs Market Size by Country

6.4.1 North America Anti-Parkinson Drugs Market Size by Country (2016-2021)

6.4.2 North America Anti-Parkinson Drugs Market Size by Country (2022-2027)

6.4.3 United States

6.4.4 Canada

7.1 Europe Anti-Parkinson Drugs Market Size (2016-2027)

7.2 Europe Anti-Parkinson Drugs Market Size by Type

7.2.1 Europe Anti-Parkinson Drugs Market Size by Type (2016-2021)

7.2.2 Europe Anti-Parkinson Drugs Market Size by Type (2022-2027)

7.2.3 Europe Anti-Parkinson Drugs Market Size by Type (2016-2027)

7.3 Europe Anti-Parkinson Drugs Market Size by Application

7.3.1 Europe Anti-Parkinson Drugs Market Size by Application (2016-2021)

7.3.2 Europe Anti-Parkinson Drugs Market Size by Application (2022-2027)

7.3.3 Europe Anti-Parkinson Drugs Market Size by Application (2016-2027)

7.4 Europe Anti-Parkinson Drugs Market Size by Country

7.4.1 Europe Anti-Parkinson Drugs Market Size by Country (2016-2021)

7.4.2 Europe Anti-Parkinson Drugs Market Size by Country (2022-2027)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic

8.1 Asia-Pacific Anti-Parkinson Drugs Market Size (2016-2027)

8.2 Asia-Pacific Anti-Parkinson Drugs Market Size by Type

8.2.1 Asia-Pacific Anti-Parkinson Drugs Market Size by Type (2016-2021)

8.2.2 Asia-Pacific Anti-Parkinson Drugs Market Size by Type (2022-2027)

8.2.3 Asia-Pacific Anti-Parkinson Drugs Market Size by Type (2016-2027)

8.3 Asia-Pacific Anti-Parkinson Drugs Market Size by Application

8.3.1 Asia-Pacific Anti-Parkinson Drugs Market Size by Application (2016-2021)

8.3.2 Asia-Pacific Anti-Parkinson Drugs Market Size by Application (2022-2027)

8.3.3 Asia-Pacific Anti-Parkinson Drugs Market Size by Application (2016-2027)

8.4 Asia-Pacific Anti-Parkinson Drugs Market Size by Region

8.4.1 Asia-Pacific Anti-Parkinson Drugs Market Size by Region (2016-2021)

8.4.2 Asia-Pacific Anti-Parkinson Drugs Market Size by Region (2022-2027)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9.1 Latin America Anti-Parkinson Drugs Market Size (2016-2027)

9.2 Latin America Anti-Parkinson Drugs Market Size by Type

9.2.1 Latin America Anti-Parkinson Drugs Market Size by Type (2016-2021)

9.2.2 Latin America Anti-Parkinson Drugs Market Size by Type (2022-2027)

9.2.3 Latin America Anti-Parkinson Drugs Market Size by Type (2016-2027)

9.3 Latin America Anti-Parkinson Drugs Market Size by Application

9.3.1 Latin America Anti-Parkinson Drugs Market Size by Application (2016-2021)

9.3.2 Latin America Anti-Parkinson Drugs Market Size by Application (2022-2027)

9.3.3 Latin America Anti-Parkinson Drugs Market Size by Application (2016-2027)

9.4 Latin America Anti-Parkinson Drugs Market Size by Country

9.4.1 Latin America Anti-Parkinson Drugs Market Size by Country (2016-2021)

9.4.2 Latin America Anti-Parkinson Drugs Market Size by Country (2022-2027)

9.4.3 Mexico

9.4.4 Brazil

10.1 Middle East & Africa Anti-Parkinson Drugs Market Size (2016-2027)

10.2 Middle East & Africa Anti-Parkinson Drugs Market Size by Type

10.2.1 Middle East & Africa Anti-Parkinson Drugs Market Size by Type (2016-2021)

10.2.2 Middle East & Africa Anti-Parkinson Drugs Market Size by Type (2022-2027)

10.2.3 Middle East & Africa Anti-Parkinson Drugs Market Size by Type (2016-2027)

10.3 Middle East & Africa Anti-Parkinson Drugs Market Size by Application

10.3.1 Middle East & Africa Anti-Parkinson Drugs Market Size by Application (2016-2021)

10.3.2 Middle East & Africa Anti-Parkinson Drugs Market Size by Application (2022-2027)

10.3.3 Middle East & Africa Anti-Parkinson Drugs Market Size by Application (2016-2027)

10.4 Middle East & Africa Anti-Parkinson Drugs Market Size by Country

10.4.1 Middle East & Africa Anti-Parkinson Drugs Market Size by Country (2016-2021)

10.4.2 Middle East & Africa Anti-Parkinson Drugs Market Size by Country (2022-2027)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11.1 AbbVie

11.1.1 AbbVie Company Details

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Anti-Parkinson Drugs Introduction

11.1.4 AbbVie Revenue in Anti-Parkinson Drugs Business (2016-2021)

11.1.5 AbbVie Recent Development

11.2 Mylan Laboratories

11.2.1 Mylan Laboratories Company Details

11.2.2 Mylan Laboratories Business Overview

11.2.3 Mylan Laboratories Anti-Parkinson Drugs Introduction

11.2.4 Mylan Laboratories Revenue in Anti-Parkinson Drugs Business (2016-2021)

11.2.5 Mylan Laboratories Recent Development

11.3 Valeant Pharmaceuticals

11.3.1 Valeant Pharmaceuticals Company Details

11.3.2 Valeant Pharmaceuticals Business Overview

11.3.3 Valeant Pharmaceuticals Anti-Parkinson Drugs Introduction

11.3.4 Valeant Pharmaceuticals Revenue in Anti-Parkinson Drugs Business (2016-2021)

11.3.5 Valeant Pharmaceuticals Recent Development

11.4 Novartis

11.4.1 Novartis Company Details

11.4.2 Novartis Business Overview

11.4.3 Novartis Anti-Parkinson Drugs Introduction

11.4.4 Novartis Revenue in Anti-Parkinson Drugs Business (2016-2021)

11.4.5 Novartis Recent Development

11.5 GlaxoSmithKline

11.5.1 GlaxoSmithKline Company Details

11.5.2 GlaxoSmithKline Business Overview

11.5.3 GlaxoSmithKline Anti-Parkinson Drugs Introduction

11.5.4 GlaxoSmithKline Revenue in Anti-Parkinson Drugs Business (2016-2021)

11.5.5 GlaxoSmithKline Recent Development

11.6 Zambon Pharmaceuticals

11.6.1 Zambon Pharmaceuticals Company Details

11.6.2 Zambon Pharmaceuticals Business Overview

11.6.3 Zambon Pharmaceuticals Anti-Parkinson Drugs Introduction

11.6.4 Zambon Pharmaceuticals Revenue in Anti-Parkinson Drugs Business (2016-2021)

11.6.5 Zambon Pharmaceuticals Recent Development

11.7 Pfizer, Inc.

11.7.1 Pfizer, Inc. Company Details

11.7.2 Pfizer, Inc. Business Overview

11.7.3 Pfizer, Inc. Anti-Parkinson Drugs Introduction

11.7.4 Pfizer, Inc. Revenue in Anti-Parkinson Drugs Business (2016-2021)

11.7.5 Pfizer, Inc. Recent Development

11.8 Hoffmann-La Roche

11.8.1 Hoffmann-La Roche Company Details

11.8.2 Hoffmann-La Roche Business Overview

11.8.3 Hoffmann-La Roche Anti-Parkinson Drugs Introduction

11.8.4 Hoffmann-La Roche Revenue in Anti-Parkinson Drugs Business (2016-2021)

11.8.5 Hoffmann-La Roche Recent Development

11.9 Merck & Co.

11.9.1 Merck & Co. Company Details

11.9.2 Merck & Co. Business Overview

11.9.3 Merck & Co. Anti-Parkinson Drugs Introduction

11.9.4 Merck & Co. Revenue in Anti-Parkinson Drugs Business (2016-2021)

11.9.5 Merck & Co. Recent Development

11.10 Orion Pharma

11.10.1 Orion Pharma Company Details

11.10.2 Orion Pharma Business Overview

11.10.3 Orion Pharma Anti-Parkinson Drugs Introduction

11.10.4 Orion Pharma Revenue in Anti-Parkinson Drugs Business (2016-2021)

11.10.5 Orion Pharma Recent Development

11.11 UCB

11.11.1 UCB Company Details

11.11.2 UCB Business Overview

11.11.3 UCB Anti-Parkinson Drugs Introduction

11.11.4 UCB Revenue in Anti-Parkinson Drugs Business (2016-2021)

11.11.5 UCB Recent Development

11.12 Teva Pharmaceutical Industries Ltd.

11.12.1 Teva Pharmaceutical Industries Ltd. Company Details

11.12.2 Teva Pharmaceutical Industries Ltd. Business Overview

11.12.3 Teva Pharmaceutical Industries Ltd. Anti-Parkinson Drugs Introduction

11.12.4 Teva Pharmaceutical Industries Ltd. Revenue in Anti-Parkinson Drugs Business (2016-2021)

11.12.5 Teva Pharmaceutical Industries Ltd. Recent Development

11.13 Vertical Pharmaceuticals, LLC

11.13.1 Vertical Pharmaceuticals, LLC Company Details

11.13.2 Vertical Pharmaceuticals, LLC Business Overview

11.13.3 Vertical Pharmaceuticals, LLC Anti-Parkinson Drugs Introduction

11.13.4 Vertical Pharmaceuticals, LLC Revenue in Anti-Parkinson Drugs Business (2016-2021)

11.13.5 Vertical Pharmaceuticals, LLC Recent Development

11.14 ACADIA Pharmaceuticals Inc.

11.14.1 ACADIA Pharmaceuticals Inc. Company Details

11.14.2 ACADIA Pharmaceuticals Inc. Business Overview

11.14.3 ACADIA Pharmaceuticals Inc. Anti-Parkinson Drugs Introduction

11.14.4 ACADIA Pharmaceuticals Inc. Revenue in Anti-Parkinson Drugs Business (2016-2021)

11.14.5 ACADIA Pharmaceuticals Inc. Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Anti-Parkinson Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027

    Table 2. Key Players of Dopaminergic

    Table 3. Key Players of Dopamine Agonists

    Table 4. Key Players of Enzyme Inhibitors

    Table 5. Key Players of Others

    Table 6. Global Anti-Parkinson Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027

    Table 7. Global Anti-Parkinson Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027

    Table 8. Global Anti-Parkinson Drugs Market Size by Regions (2016-2021) & (US$ Million)

    Table 9. Global Anti-Parkinson Drugs Market Share by Regions (2016-2021)

    Table 10. Global Anti-Parkinson Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)

    Table 11. Global Anti-Parkinson Drugs Market Share by Regions (2022-2027)

    Table 12. Anti-Parkinson Drugs Market Trends

    Table 13. Anti-Parkinson Drugs Market Drivers

    Table 14. Anti-Parkinson Drugs Market Challenges

    Table 15. Anti-Parkinson Drugs Market Restraints

    Table 16. Global Anti-Parkinson Drugs Revenue by Players (2016-2021) & (US$ Million)

    Table 17. Global Anti-Parkinson Drugs Market Share by Players (2016-2021)

    Table 18. Global Top Anti-Parkinson Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Parkinson Drugs as of 2020)

    Table 19. Ranking of Global Top Anti-Parkinson Drugs Companies by Revenue (US$ Million) in 2020

    Table 20. Global 5 Largest Players Market Share by Anti-Parkinson Drugs Revenue (CR5 and HHI) & (2016-2021)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Anti-Parkinson Drugs Product Solution and Service

    Table 23. Date of Enter into Anti-Parkinson Drugs Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Anti-Parkinson Drugs Market Size by Type (2016-2021) (US$ Million)

    Table 26. Global Anti-Parkinson Drugs Revenue Market Share by Type (2016-2021)

    Table 27. Global Anti-Parkinson Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)

    Table 28. Global Anti-Parkinson Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)

    Table 29. Global Anti-Parkinson Drugs Market Size Share by Application (2016-2021) & (US$ Million)

    Table 30. Global Anti-Parkinson Drugs Revenue Market Share by Application (2016-2021)

    Table 31. Global Anti-Parkinson Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)

    Table 32. Global Anti-Parkinson Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)

    Table 33. North America Anti-Parkinson Drugs Market Size by Type (2016-2021) (US$ Million)

    Table 34. North America Anti-Parkinson Drugs Market Size by Type (2022-2027) & (US$ Million)

    Table 35. North America Anti-Parkinson Drugs Market Size by Application (2016-2021) (US$ Million)

    Table 36. North America Anti-Parkinson Drugs Market Size by Application (2022-2027) & (US$ Million)

    Table 37. North America Anti-Parkinson Drugs Market Size by Country (2016-2021) & (US$ Million)

    Table 38. North America Anti-Parkinson Drugs Market Size by Country (2022-2027) & (US$ Million)

    Table 39. Europe Anti-Parkinson Drugs Market Size by Type (2016-2021) (US$ Million)

    Table 40. Europe Anti-Parkinson Drugs Market Size by Type (2022-2027) & (US$ Million)

    Table 41. Europe Anti-Parkinson Drugs Market Size by Application (2016-2021) (US$ Million)

    Table 42. Europe Anti-Parkinson Drugs Market Size by Application (2022-2027) & (US$ Million)

    Table 43. Europe Anti-Parkinson Drugs Market Size by Country (2016-2021) & (US$ Million)

    Table 44. Europe Anti-Parkinson Drugs Market Size by Country (2022-2027) & (US$ Million)

    Table 45. Asia-Pacific Anti-Parkinson Drugs Market Size by Type (2016-2021) (US$ Million)

    Table 46. Asia-Pacific Anti-Parkinson Drugs Market Size by Type (2022-2027) & (US$ Million)

    Table 47. Asia-Pacific Anti-Parkinson Drugs Market Size by Application (2016-2021) (US$ Million)

    Table 48. Asia-Pacific Anti-Parkinson Drugs Market Size by Application (2022-2027) & (US$ Million)

    Table 49. Asia-Pacific Anti-Parkinson Drugs Market Size by Region (2016-2021) & (US$ Million)

    Table 50. Asia-Pacific Anti-Parkinson Drugs Market Size by Region (2022-2027) & (US$ Million)

    Table 51. Latin America Anti-Parkinson Drugs Market Size by Type (2016-2021) (US$ Million)

    Table 52. Latin America Anti-Parkinson Drugs Market Size by Type (2022-2027) & (US$ Million)

    Table 53. Latin America Anti-Parkinson Drugs Market Size by Application (2016-2021) (US$ Million)

    Table 54. Latin America Anti-Parkinson Drugs Market Size by Application (2022-2027) & (US$ Million)

    Table 55. Latin America Anti-Parkinson Drugs Market Size by Country (2016-2021) & (US$ Million)

    Table 56. Latin America Anti-Parkinson Drugs Market Size by Country (2022-2027) & (US$ Million)

    Table 57. Middle East & Africa Anti-Parkinson Drugs Market Size by Type (2016-2021) (US$ Million)

    Table 58. Middle East & Africa Anti-Parkinson Drugs Market Size by Type (2022-2027) & (US$ Million)

    Table 59. Middle East & Africa Anti-Parkinson Drugs Market Size by Application (2016-2021) (US$ Million)

    Table 60. Middle East & Africa Anti-Parkinson Drugs Market Size by Application (2022-2027) & (US$ Million)

    Table 61. Middle East & Africa Anti-Parkinson Drugs Market Size by Country (2016-2021) & (US$ Million)

    Table 62. Middle East & Africa Anti-Parkinson Drugs Market Size by Country (2022-2027) & (US$ Million)

    Table 63. AbbVie Company Details

    Table 64. AbbVie Business Overview

    Table 65. AbbVie Anti-Parkinson Drugs Product

    Table 66. AbbVie Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million)

    Table 67. AbbVie Recent Development

    Table 68. Mylan Laboratories Company Details

    Table 69. Mylan Laboratories Business Overview

    Table 70. Mylan Laboratories Anti-Parkinson Drugs Product

    Table 71. Mylan Laboratories Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million)

    Table 72. Mylan Laboratories Recent Development

    Table 73. Valeant Pharmaceuticals Company Details

    Table 74. Valeant Pharmaceuticals Business Overview

    Table 75. Valeant Pharmaceuticals Anti-Parkinson Drugs Product

    Table 76. Valeant Pharmaceuticals Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million)

    Table 77. Valeant Pharmaceuticals Recent Development

    Table 78. Novartis Company Details

    Table 79. Novartis Business Overview

    Table 80. Novartis Anti-Parkinson Drugs Product

    Table 81. Novartis Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million)

    Table 82. Novartis Recent Development

    Table 83. GlaxoSmithKline Company Details

    Table 84. GlaxoSmithKline Business Overview

    Table 85. GlaxoSmithKline Anti-Parkinson Drugs Product

    Table 86. GlaxoSmithKline Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million)

    Table 87. GlaxoSmithKline Recent Development

    Table 88. Zambon Pharmaceuticals Company Details

    Table 89. Zambon Pharmaceuticals Business Overview

    Table 90. Zambon Pharmaceuticals Anti-Parkinson Drugs Product

    Table 91. Zambon Pharmaceuticals Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million)

    Table 92. Zambon Pharmaceuticals Recent Development

    Table 93. Pfizer, Inc. Company Details

    Table 94. Pfizer, Inc. Business Overview

    Table 95. Pfizer, Inc. Anti-Parkinson Drugs Product

    Table 96. Pfizer, Inc. Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million)

    Table 97. Pfizer, Inc. Recent Development

    Table 98. Hoffmann-La Roche Company Details

    Table 99. Hoffmann-La Roche Business Overview

    Table 100. Hoffmann-La Roche Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million)

    Table 101. Hoffmann-La Roche Recent Development

    Table 102. Merck & Co. Company Details

    Table 103. Merck & Co. Business Overview

    Table 104. Merck & Co. Anti-Parkinson Drugs Product

    Table 105. Merck & Co. Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million)

    Table 106. Merck & Co. Recent Development

    Table 107. Orion Pharma Company Details

    Table 108. Orion Pharma Business Overview

    Table 109. Orion Pharma Anti-Parkinson Drugs Product

    Table 110. Orion Pharma Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million)

    Table 111. Orion Pharma Recent Development

    Table 112. UCB Company Details

    Table 113. UCB Business Overview

    Table 114. UCB Anti-Parkinson Drugs Product

    Table 115. UCB Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million)

    Table 116. UCB Recent Development

    Table 117. Teva Pharmaceutical Industries Ltd. Company Details

    Table 118. Teva Pharmaceutical Industries Ltd. Business Overview

    Table 119. Teva Pharmaceutical Industries Ltd. Anti-Parkinson Drugs Product

    Table 120. Teva Pharmaceutical Industries Ltd. Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million)

    Table 121. Teva Pharmaceutical Industries Ltd. Recent Development

    Table 122. Vertical Pharmaceuticals, LLC Company Details

    Table 123. Vertical Pharmaceuticals, LLC Business Overview

    Table 124. Vertical Pharmaceuticals, LLC Anti-Parkinson Drugs Product

    Table 125. Vertical Pharmaceuticals, LLC Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million)

    Table 126. Vertical Pharmaceuticals, LLC Recent Development

    Table 127. ACADIA Pharmaceuticals Inc. Company Details

    Table 128. ACADIA Pharmaceuticals Inc. Business Overview

    Table 129. ACADIA Pharmaceuticals Inc. Anti-Parkinson Drugs Product

    Table 130. ACADIA Pharmaceuticals Inc. Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million)

    Table 131. ACADIA Pharmaceuticals Inc. Recent Development

    Table 132. Research Programs/Design for This Report

    Table 133. Key Data Information from Secondary Sources

    Table 134. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Anti-Parkinson Drugs Market Share by Type: 2020 VS 2027

    Figure 2. Dopaminergic Features

    Figure 3. Dopamine Agonists Features

    Figure 4. Enzyme Inhibitors Features

    Figure 5. Others Features

    Figure 6. Global Anti-Parkinson Drugs Market Share by Application: 2020 VS 2027

    Figure 7. Hospital Pharmacy Case Studies

    Figure 8. Retail Pharmacy Case Studies

    Figure 9. Online Stores Case Studies

    Figure 10. Anti-Parkinson Drugs Report Years Considered

    Figure 11. Global Anti-Parkinson Drugs Market Size (US$ Million), Year-over-Year: 2016-2027

    Figure 12. Global Anti-Parkinson Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027

    Figure 13. Global Anti-Parkinson Drugs Market Share by Regions: 2020 VS 2027

    Figure 14. Global Anti-Parkinson Drugs Market Share by Regions (2022-2027)

    Figure 15. Global Anti-Parkinson Drugs Market Share by Players in 2020

    Figure 16. Global Top Anti-Parkinson Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Parkinson Drugs as of 2020

    Figure 17. The Top 10 and 5 Players Market Share by Anti-Parkinson Drugs Revenue in 2020

    Figure 18. Global Anti-Parkinson Drugs Revenue Market Share by Type (2016-2021)

    Figure 19. Global Anti-Parkinson Drugs Revenue Market Share by Type (2022-2027)

    Figure 20. North America Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 21. North America Anti-Parkinson Drugs Market Share by Type (2016-2027)

    Figure 22. North America Anti-Parkinson Drugs Market Share by Application (2016-2027)

    Figure 23. North America Anti-Parkinson Drugs Market Share by Country (2016-2027)

    Figure 24. United States Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 25. Canada Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 26. Europe Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 27. Europe Anti-Parkinson Drugs Market Share by Type (2016-2027)

    Figure 28. Europe Anti-Parkinson Drugs Market Share by Application (2016-2027)

    Figure 29. Europe Anti-Parkinson Drugs Market Share by Country (2016-2027)

    Figure 30. Germany Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 31. France Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 32. U.K. Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 33. Italy Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 34. Russia Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 35. Nordic Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 36. Asia-Pacific Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 37. Asia-Pacific Anti-Parkinson Drugs Market Share by Type (2016-2027)

    Figure 38. Asia-Pacific Anti-Parkinson Drugs Market Share by Application (2016-2027)

    Figure 39. Asia-Pacific Anti-Parkinson Drugs Market Share by Region (2016-2027)

    Figure 40. China Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 41. Japan Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 42. South Korea Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 43. Southeast Asia Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 44. India Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 45. Australia Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 46. Latin America Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 47. Latin America Anti-Parkinson Drugs Market Share by Type (2016-2027)

    Figure 48. Latin America Anti-Parkinson Drugs Market Share by Application (2016-2027)

    Figure 49. Latin America Anti-Parkinson Drugs Market Share by Country (2016-2027)

    Figure 50. Mexico Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 51. Brazil Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 52. Middle East & Africa Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 53. Middle East & Africa Anti-Parkinson Drugs Market Share by Type (2016-2027)

    Figure 54. Middle East & Africa Anti-Parkinson Drugs Market Share by Application (2016-2027)

    Figure 55. Middle East & Africa Anti-Parkinson Drugs Market Share by Country (2016-2027)

    Figure 56. Turkey Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 57. Saudi Arabia Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 58. UAE Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 59. AbbVie Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021)

    Figure 60. Mylan Laboratories Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021)

    Figure 61. Valeant Pharmaceuticals Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021)

    Figure 62. Novartis Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021)

    Figure 63. GlaxoSmithKline Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021)

    Figure 64. Zambon Pharmaceuticals Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021)

    Figure 65. Pfizer, Inc. Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021)

    Figure 66. Hoffmann-La Roche Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021)

    Figure 67. Merck & Co. Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021)

    Figure 68. Orion Pharma Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021)

    Figure 69. UCB Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021)

    Figure 70. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021)

    Figure 71. Vertical Pharmaceuticals, LLC Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021)

    Figure 72. ACADIA Pharmaceuticals Inc. Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021)

    Figure 73. Bottom-up and Top-down Approaches for This Report

    Figure 74. Data Triangulation

    Figure 75. Key Executives Interviewed